FDA warns of rare secondary cancer risk with CAR-T therapies

The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary cancer.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart